Learn More

May 18, 2023 | Volume XIV | Issue 20

FTC expands probe into pharmacy benefit managers

Paige Minemyer reports for Fierce Healthcare:

The Federal Trade Commission (FTC) is expanding its probe into pharmacy benefit managers by issuing compulsory orders to two group purchasing organizations that negotiate rebates on behalf of PBMs.

The FTC said late Wednesday that the orders will require Zinc Health Services and Ascent Health Services to provide key details and information on their business practices.

Read More

Many people are tired of grappling with long COVID – here are some evidence-based ways to counter it

Kyle B. Enfield, University of Virginia

A patient of mine, once a marathon runner, now gets tired just walking around the block. She developed COVID-19 during the 2020 Christmas holiday and saw me during the summer of 2021. Previously, her primary care doctor had recommended a graded exercise program. But exercise exhausted her. After months of waiting, she finally had an appointment at our post-COVID-19 clinic at the University of Virginia.

She is hardly alone in her extended search for answers. Studies suggest that from 10% to 45% of COVID-19 survivors have at least one of the following symptoms three months after recovery: fatigue, cough, shortness of breath, difficulty sleeping, difficulty with daily activities or mental fogginess, otherwise known as “brain fog.”

There are many names for this condition: long COVID, long-haul COVID, post-acute COVID-19 syndrome and chronic COVID. Patients report that their symptoms, or the severity of them, fluctuate over time, which makes diagnosis and treatment difficult.

Read More

Wegovy 'no silver bullet' according to WHO

Reuters reports via CNBC:

New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

The global health body is first revising guidelines for treating children and adolescents with obesity, and will then update recommendations for adults, said Francesco Branca, WHO director of nutrition and food safety.

Read More

A vaccine for pancreatic cancer is showing promise. Here's how it works.

CBS News

A vaccine is showing promise in staving off the return of one of the deadliest forms of cancer. The vaccine provoked an immune response in half of the pancreatic cancer patients treated during a recent clinical trial, and patients showed no recurrence of their cancer during the course of the years long study. Dr. Vinod Balachandran, an attending surgeon at Memorial Sloan Kettering Cancer Center and leader of the team behind this pancreatic cancer vaccine trial, joined CBS News to talk about the trial.

Watch the video HERE.

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers